ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• You Don't Have To Digitize Everything, You Just Have To Start

  Feeling left behind by the sudden digitization of clinical trials? Decentralized clinical trials can be adapted to best serve the patient population, condition, or therapy you’re investigating.

• Using IRT Data To Automate And Optimize Clinical Supply

  Learn how clinical teams can save between $150,000 and $1 million in annual drug and shipping costs through automated supply optimization.

• Build Vs. Buy Vs. Partner In Life Sciences: Making The Right Call

  Discover when life sciences organizations should develop technology in-house, buy off-the-shelf solutions, or form strategic partnerships, exploring the costs and risks that come with each approach.

• Optimizing Data Capture From Protocol Design To Efficacy Endpoints

  The shift to digital trials favors the 11-point NRS over the traditional VAS to reduce data noise, improve elderly patient compliance, and ensure statistical power across mobile devices.

• How To Overcome The Problem Of The Early ePRO Oversell

  In this blog, explore how the approach to PROs needs to be reconsidered, given increasing regulations and trial scrutiny, the clinical need for patient-reported outcomes, and the ability to drive costs down and move off paper.

• Rewind The Clock And Take TMF Back To Basics

  Consider the evolution of Trial Master Files (TMF) in clinical trials when tackling the paradigm of maintaining simplicity while embracing technology.

• Statistics & Data Management Group Reaches New Heights Of Clinical Trial Efficiency

  Explore how a contract research organization was able to migrate from paper-based processes to cost-effectively increase efficiency, safeguard data quality, and deliver exceptional service levels to sponsors.

• Simple, Cost-Effective Ways To Engage Patients Using eCOA And IRT

  Today, patients are exposed to sophisticated technology, which presents a huge opportunity to elevate engagement. Consider some common elements when initiating engagement during clinical development.

• Reducing Risks And Accelerating Study Startup Through An eCOA Library

  Find out how the shift towards a more patient-centric drug development landscape has made Clinical Outcome Assessments (COAs) an increasingly necessary and often required tool to gather patient experience data in most trials today.

• Paperless Online Remote Source Document Verification

  Learn how Clinical Trial Organizations, Monitoring Teams and Clinical Sites can benefit from the way Judi transforms rSDV from a logistical hurdle into a strategic asset.